Search
Search
Close this search box.
Search
Close this search box.

NDEA

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims

Product Liability / July 24, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , , , ,

Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a […]

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

Product Liability / June 24, 2024 / 3 minutes of reading / By / , , , , , , , , , , , , , ,

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Scroll to Top